380 related articles for article (PubMed ID: 31229399)
21. Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome.
Siamashvili M; Davis SN
Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1081-1089. PubMed ID: 34015974
[No Abstract] [Full Text] [Related]
22. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
23. Comparative efficacy of thiazolidinediones and metformin for polycystic ovary syndrome.
Du Q; Wang YJ
Saudi Med J; 2012 Sep; 33(9):954-61. PubMed ID: 22964806
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.
Ali Fadlalmola H; Elhusein AM; Al-Sayaghi KM; Albadrani MS; Swamy DV; Mamanao DM; El-Amin EI; Ibrahim SE; Abbas SM
Pan Afr Med J; 2023; 44():134. PubMed ID: 37333786
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.
Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA
BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801
[TBL] [Abstract][Full Text] [Related]
26. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
[TBL] [Abstract][Full Text] [Related]
27. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Karakoç A; Törüner F; Bingöl B; Cakir N; Tiras B; Ayvaz G; Arslan M
J Endocrinol Invest; 2005 Dec; 28(11):1003-8. PubMed ID: 16483179
[TBL] [Abstract][Full Text] [Related]
28. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
29. Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies.
Li L; Li S; Liu J; Deng K; Busse JW; Vandvik PO; Wong E; Sohani ZN; Bala MM; Rios LP; Malaga G; Ebrahim S; Shen J; Zhang L; Zhao P; Chen Q; Wang Y; Guyatt GH; Sun X
BMC Cardiovasc Disord; 2016 May; 16():91. PubMed ID: 27169565
[TBL] [Abstract][Full Text] [Related]
30. Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
Pugliese G; de Alteriis G; Muscogiuri G; Barrea L; Verde L; Zumbolo F; Colao A; Savastano S
J Endocrinol Invest; 2023 Sep; 46(9):1761-1774. PubMed ID: 37093453
[TBL] [Abstract][Full Text] [Related]
31. Effects of acarbose on polycystic ovary syndrome: a meta-analysis.
Zhang YY; Hou LQ; Zhao TY
Exp Clin Endocrinol Diabetes; 2014 Jun; 122(6):373-8. PubMed ID: 24941435
[TBL] [Abstract][Full Text] [Related]
32. Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome: a meta-analysis: A PRISMA-compliant article.
Wang J; Zhu L; Hu K; Tang Y; Zeng X; Liu J; Xu J
Medicine (Baltimore); 2017 Sep; 96(39):e8183. PubMed ID: 28953677
[TBL] [Abstract][Full Text] [Related]
33. Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study.
Sahin I; Serter R; Karakurt F; Demirbas B; Culha C; Taskapan C; Kosar F; Aral Y
Gynecol Endocrinol; 2004 Sep; 19(3):115-24. PubMed ID: 15697072
[TBL] [Abstract][Full Text] [Related]
34. The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome.
Bednarz K; Kowalczyk K; Cwynar M; Czapla D; Czarkowski W; Kmita D; Nowak A; Madej P
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457152
[TBL] [Abstract][Full Text] [Related]
35. Metformin Therapy for Acne in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.
Yen H; Chang YT; Yee FJ; Huang YC
Am J Clin Dermatol; 2021 Jan; 22(1):11-23. PubMed ID: 33048332
[TBL] [Abstract][Full Text] [Related]
36. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
Morin-Papunen LC; Vauhkonen I; Koivunen RM; Ruokonen A; Martikainen HK; Tapanainen JS
J Clin Endocrinol Metab; 2000 Sep; 85(9):3161-8. PubMed ID: 10999803
[TBL] [Abstract][Full Text] [Related]
37. Comparison of exenatide alone or combined with metformin versus metformin in the treatment of polycystic ovaries: a systematic review and meta-analysis.
Hu Y; Song X; Hamiti S; Ma Y; Yusufu M; Wang X; Zhang K; Guo Y
BMC Endocr Disord; 2023 Nov; 23(1):250. PubMed ID: 37974132
[TBL] [Abstract][Full Text] [Related]
38. Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis.
Fatima K; Jamil Z; Faheem S; Adnan A; Javaid SS; Naeem H; Mohiuddin N; Sajid A; Ochani S
Ir J Med Sci; 2023 Dec; 192(6):2801-2808. PubMed ID: 37148410
[TBL] [Abstract][Full Text] [Related]
39. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
40. Oral contraceptives (OCs) in combination with metformin versus OCs alone on metabolism in nonobese polycystic ovary syndrome: A meta-analysis and systematic review of randomized controlled trials.
Wu L; Liu Y; Huang X; Lin K; Liu Y; Li Z; Wei T; Song L; Hua Y; Wang X
Clin Endocrinol (Oxf); 2023 Jul; 99(1):3-16. PubMed ID: 36799083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
